A meta-analysis on immune checkpoint inhibitor efficacy for advanced non-small cell lung cancer between East Asians versus non-East Asians
10.21037/tlcr-20-246
Saved in:
Main Authors: | Peng, S., Ying, A.F., Tai, B.C., Soo, R.A. |
---|---|
Other Authors: | DUKE-NUS MEDICAL SCHOOL |
Format: | Article |
Published: |
AME Publishing Company
2021
|
Subjects: | |
Online Access: | https://scholarbank.nus.edu.sg/handle/10635/197607 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Differences in outcome and toxicity between Asian and caucasian patients with lung cancer treated with systemic therapy
by: Soo, R.A., et al.
Published: (2014) -
Clinical and testing protocols for the analysis of epidermal growth factor receptor mutations in East Asian patients with non-small cell lung cancer: A combined clinical-molecular pathological approach
by: Salto-Tellez, M., et al.
Published: (2014) -
PD-1/PD-L1 pathway and T-cell exhaustion in chronic hepatitis virus infection
by: Watanabe, T., et al.
Published: (2011) -
Combining DNA damaging therapeutics with immunotherapy: more haste, less speed
by: Brown, Jessica S, et al.
Published: (2022) -
Randomized controlled trial of S-1 versus docetaxel in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy (East Asia S-1 Trial in Lung Cancer)
by: Nokihara, H, et al.
Published: (2022)